RT Journal
A1 Hildreth CJ
T1 ANgiogenesis and cancer
JF JAMA
JO JAMA
YR 2009
FD January 7
VO 301
IS 1
SP 26
OP 26
DO 10.1001/jama.2008.924
UL http://dx.doi.org/10.1001/jama.2008.924
AB 
Evidence that angiogenesis, the development of new blood vessels, is important for tumor progression prompted interest in drugs that inhibit angiogenesis-promoting proteins, such as vascular endothelial growth factor (VEGF). Now, however, researchers from the University of California, San Diego, in La Jolla, have discovered VEGF-blocking drugs may actually accelerate tumor cell growth (Stockmann C et al. Nature. doi:10.1038/nature07445 [published online ahead of print November 9, 2008]).